Cargando…
High expression of Myosin 1g in pediatric acute lymphoblastic leukemia
Acute Lymphoblastic Leukemia (ALL) is the most frequent cancer in pediatric population. Although the treatment has improved and almost 85% of the children are cured about 20% suffer relapse, therefore finding molecules that participate in the pathogenesis of the disease for the identification of rel...
Autores principales: | Estrada-Abreo, Laura A., Rodríguez-Cruz, Leonor, Garfias-Gómez, Yanelly, Araujo-Cardenas, Janeth E., Antonio-Andrés, Gabriela, Salgado-Aguayo, Alfonso R., Orozco-Ruiz, Darío, Torres-Nava, José Refugio, Díaz-Valencia, Juan D., Huerta-Yépez, Sara, Patiño-López, Genaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448507/ https://www.ncbi.nlm.nih.gov/pubmed/34548909 http://dx.doi.org/10.18632/oncotarget.28055 |
Ejemplares similares
-
Class I Myosins, molecular motors involved in cell migration and cancer
por: Diaz-Valencia, Juan D., et al.
Publicado: (2022) -
Transcriptional Regulation of Yin-Yang 1 Expression through the Hypoxia Inducible Factor-1 in Pediatric Acute Lymphoblastic Leukemia
por: Antonio-Andres, Gabriela, et al.
Publicado: (2022) -
Detection of Myosin 1g Overexpression in Pediatric Leukemia by Novel Monoclonal Antibodies
por: Rodríguez-Téllez, Rosa Isela, et al.
Publicado: (2022) -
2386. Mortality reduction with implementation of a standardized approach of surveillance, diagnosis and treatment of Clostridioides difficile infections.
por: Molina, Aaron, et al.
Publicado: (2019) -
Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment
por: Díaz-Barriga, Cristina, et al.
Publicado: (2021)